Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-12

Clinical Trial Update: Thalamic Deep Brain Stimulation for Tourette Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on thalamic deep brain stimulation for Tourette Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Tourette Syndrome | Phase 2 | Status: COMPLETED